The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy
Open accessAbstract
Objectives We compared the safety, tolerance and effectiveness of overdrive high right atrial (RA), dual-site RA and support (DDI or VDI) pacing (SP) in patients with symptomatic atrial fibrillation (AF) and bradycardias.Background Optimal pacing methods for AF prevention remain unclear.Methods Patients (n = 118) were randomized to each of three pacing modes in a crossover trial.Results Mode adherence was superior for dual-site RA (5.8 months) compared with SP (3.3 months; p < 0.001) and high RA pacing (4.7 months; p = 0.006). Adverse event-free survival improved with dual-site RA (p = 0.007 vs. SP) and was comparable to high RA (p = 0. 75). AF-free survival trended to improve with dual-site RA (hazard ratio [HR] 0.715, p = 0.07 vs. SP) but not high RA (HR = 0.71, p = 0.19) or when dual-site RA was compared with high RA (HR = 0.835, p = 0.175). Time-to-recurrence was longer in dual-site RA (1.77 months) compared with high RA (0.62 months, p < 0.09) or SP (0.44 months, p < 0.05). In antiarrhythmic drug-treated patients, dual-site RA reduced recurrence risk compared with SP (HR = 0.638, p = 0.011) and high RA (HR = 0.669, p = 0.06). In patients with < or =1 AF event/week, dual-site RA improved AF suppression (HR = 0.464, p = 0.004 vs. SP; HR = 0.623, p = 0.006 vs. high RA). Dual-site RA improved AF-free and mode survival (p < 0.03 vs. high RA, p < 0.001 vs. SP) and reduced asymptomatic AF (p < 0.01 vs. high RA).Conclusion Dual-site RA is safe and better tolerated than high RA and SP. In patients on antiarrhythmics, dual-site RA prolonged and high RA trended to prolong time-to-recurrent AF compared with SP. Dual-site RA provides superior symptomatic and asymptomatic AF prevention compared with high RA in patients with symptomatic AF frequency of < or =1/week.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the existing populations studied are highly selected.839,840”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [839]
In the citing paper
“Such strategies have never been prospectively investigated”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [839]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M. R., Dorian, P., Connolly, S. J., Eisenberg, M. J., Green, M. S., Kuś, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,142
Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
Lamas, G. A., Lee, K. L., Sweeney, M. O., Silverman, R., León, A. R., Yee, R. K., Marinchak, R. A., Flaker, G., SCHRON, E. B., Orav, E. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013040 · Cited by 994
Andersen, H. R., Nielsen, J. C., Thomsen, P. E. B., Thuesen, L., Mortensen, P. T., Vesterlund, T., & Pedersen, A. K. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03425-9 · Cited by 841
Connolly, S. J., Kerr, C. R., Gent, M., Roberts, R. S., Yusuf, S., Gillis, A. M., Sami, M. H., Talajic, M., Tang, A. S. L., Klein, G. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421902 · Cited by 775
Prevention of Recurrent Atrial Fibrillation With Chronic Dual-Site Right Atrial Pacing
Saksena, S. V., Prakash, A., Hill, M., Król, R. B., Munsif, A. N., Mathew, P., & Mehra, R. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00232-x · Cited by 325
Self-citationAnderson, J. L., Gilbert, E. M., Alpert, B. L., Henthorn, R. W., Waldo, A. L., Bhandari, A. K., Hawkinson, R. W., & Pritchett, E. L. C. (1989) · Circulation · doi:10.1161/01.cir.80.6.1557 · Cited by 287
Delfaut, P., Saksena, S. V., Prakash, A., & Król, R. B. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00489-6 · Cited by 225
Self-citationGelder, I. C. V., Crijns, H. J. G. M., van Gilst, W. H., van Wijk, L. M., Hamer, H. P. M., & Lie, K. I. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90574-2 · Cited by 187
WIJFFELS, M. C. E. F., Dorland, R., MAST, F., & Allessie, M. A. (2000) · Circulation · doi:10.1161/01.cir.102.2.260 · Cited by 183
Research works printed but not linked: 2
- Daubert, 1994, Atrial tachyarrhythmias associated with high degree interatrial conduction block, Eur J Card Pacing Electrophysiol, 1, 35
- Prakash, 2001, Dual-site atrial pacing for prevention of atrial fibrillation (DAPPAF) trial, PACE, 24, 553
Cited by
Sorted by citations
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 928
Metadata
- Authors
- Saksena, S., Prakash, A., Ziegler, P., Hummel, J. D., Friedman, P., Plumb, V. J., Wyse, D. G., Johnson, E., Fitts, S., & Mehra, R.
- Affiliations
- Atlantic Health System (US)
- Medtronic (United States) (US)
- Mayo Clinic (US)
- University of Alabama at Birmingham (US)
- University of Calgary (CA)
- The Stern Cardiovascular Foundation (US)
- Corresponding author
- Saksena, Sanjeev
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 40
- Issue
- 6
- Pages
- 1140-1150
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2150916657
- Cited by
- 171
- References
- 20
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 4
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- atrial fibrillation suppression, overdrive pacing, antiarrhythmic drugs, atrial fibrillation recurrence, bradycardia, atrial fibrillation prevention, asymptomatic atrial fibrillation, crossover trial
- MeSH terms
- Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Bradycardia, Cardiac Pacing, Artificial, Combined Modality Therapy, Female, Heart Atria, Humans, Male, Middle Aged, Prospective Studies, Time Factors, Cross-Over Studies, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
